X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (1613) 1613
humans (1205) 1205
antifungal agents - pharmacology (954) 954
microbiology (862) 862
echinocandins (847) 847
pharmacology & pharmacy (652) 652
echinocandins - pharmacology (645) 645
antifungal agents - therapeutic use (640) 640
microbial sensitivity tests (607) 607
lipopeptides (586) 586
caspofungin (583) 583
infectious diseases (525) 525
antifungal agents (479) 479
fluconazole (442) 442
candida - drug effects (435) 435
drug resistance, fungal (427) 427
amphotericin-b (400) 400
echinocandins - therapeutic use (384) 384
male (376) 376
candidiasis - drug therapy (358) 358
micafungin (351) 351
voriconazole (340) 340
female (332) 332
susceptibility (320) 320
mycology (319) 319
bacterial infections and mycoses (312) 312
echinocandin (301) 301
candida (298) 298
candidiasis - microbiology (297) 297
resistance (289) 289
invasive candidiasis (281) 281
animals (277) 277
epidemiology (261) 261
candida albicans - drug effects (242) 242
middle aged (240) 240
candidiasis (235) 235
mycoses (228) 228
amphotericin b (222) 222
candida - isolation & purification (222) 222
adult (220) 220
anidulafungin (213) 213
infections (213) 213
amphotericin b - pharmacology (207) 207
fungi (203) 203
aged (195) 195
lipopeptides - pharmacology (187) 187
health aspects (184) 184
mycoses - drug therapy (180) 180
treatment outcome (178) 178
fluconazole - pharmacology (176) 176
in-vitro (172) 172
antifungal agents - administration & dosage (169) 169
fungal proteins - genetics (167) 167
candidemia (163) 163
liposomal amphotericin-b (162) 162
albicans (160) 160
azoles (156) 156
echinocandin resistance (156) 156
blood-stream infections (155) 155
candida-albicans (155) 155
triazoles - pharmacology (153) 153
mutation (152) 152
candida glabrata - drug effects (147) 147
infection (146) 146
mortality (144) 144
antifungal susceptibility (143) 143
aspergillosis (142) 142
fungal infections (142) 142
fungal-infections (141) 141
peptides, cyclic - pharmacology (140) 140
yeast (138) 138
amphotericin b - therapeutic use (136) 136
drug resistance (136) 136
aspergillosis - drug therapy (135) 135
candida albicans (135) 135
drug therapy (135) 135
mice (135) 135
candida - classification (133) 133
internal medicine (133) 133
therapy (131) 131
echinocandins - administration & dosage (130) 130
itraconazole (130) 130
aspergillus (129) 129
triazoles - therapeutic use (126) 126
analysis (125) 125
drug therapy, combination (125) 125
research (125) 125
pharmacokinetics (124) 124
saccharomyces-cerevisiae (120) 120
in-vitro activity (119) 119
antifungal agents - pharmacokinetics (117) 117
immunology (117) 117
peptides, cyclic - therapeutic use (116) 116
antifungal agents - adverse effects (115) 115
polycyclic compounds (115) 115
surveillance (114) 114
invasive fungal-infections (111) 111
microbial sensitivity tests - methods (111) 111
antifungal (109) 109
drug resistance, fungal - genetics (108) 108
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1839) 1839
Spanish (26) 26
French (21) 21
Japanese (15) 15
German (10) 10
Turkish (3) 3
Russian (2) 2
Chinese (1) 1
Czech (1) 1
Danish (1) 1
Dutch (1) 1
Estonian (1) 1
Italian (1) 1
Korean (1) 1
Norwegian (1) 1
Polish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
Journal Article
Antimicrobial agents and chemotherapy, ISSN 0066-4804, 01/2019, Volume 63, Issue 1
Candida auris is an emerging multidrug-resistant yeast that can cause serious invasive infections. The accurate and rapid assessment of antifungal resistance... 
Candida auris | echinocandin | ERG11 | resistance | azole | FKS | molecular beacons | MICROBIOLOGY | PHARMACOLOGY & PHARMACY
Journal Article
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 6/2013, Volume 56, Issue 12, pp. 1724 - 1732
Background. Fluconazole (FLC) resistance is common in C. glabrata and echinocandins are often used as first-line therapy. Resistance to echinocandin therapy... 
Antifungals | Azoles | Health outcomes | Microbial sensitivity tests | Mortality | Polyenes | Infections | Candida glabrata | ARTICLES AND COMMENTARIES | Genetic mutation | Blood | susceptibility | micafungin | resistance | echinocandin | CASPOFUNGIN | INFECTIOUS DISEASES | ASPERGILLUS-FUMIGATUS | MICROBIOLOGY | IMMUNOLOGY | CHANGING EPIDEMIOLOGY | IN-VITRO | ANTIFUNGAL AGENTS | 1,3-BETA-D-GLUCAN SYNTHASE | ALBICANS | BLOOD-STREAM INFECTIONS | INVASIVE CANDIDIASIS | Humans | Middle Aged | Child, Preschool | Infant | Male | Candidiasis - microbiology | Antifungal Agents - therapeutic use | Microbial Sensitivity Tests | Candidiasis - drug therapy | Aged, 80 and over | Adult | Female | Retrospective Studies | Child | Drug Resistance, Fungal | Echinocandins - pharmacology | Infant, Newborn | Glucosyltransferases - genetics | Antifungal Agents - pharmacology | Membrane Proteins - genetics | Treatment Outcome | Fungal Proteins - genetics | Mutation - genetics | Adolescent | Echinocandins - therapeutic use | Aged | Candida glabrata - genetics | Candida glabrata - drug effects | Complications and side effects | Drug resistance in microorganisms | Candidiasis | Gene mutations | Echinocandins | Dosage and administration | Genetic aspects | Research | Drug therapy | Risk factors | Fungal infections | Mutation | Drug resistance | Genes | Pesticides | Index Medicus | and Commentaries
Journal Article
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 12/2015, Volume 61, Issue 11, p. S612
Journal Article
PLoS Pathogens, ISSN 1553-7366, 09/2011, Volume 7, Issue 9, pp. e1002257 - e1002257
Journal Article
Journal Article